Loading…
Reported covered position: Legal fellowship with Sen. Blanche Lincoln; Sr. Counsel/Advisor for Rep. Marion Berry; Sr. Counsel/Advisor for Rep. Tim Walz
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
TEST Act of 2015
Client: THE INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS · Firm: ROSE LAW FIRM, A PROFESSIONAL ASSOCIATION
Legislation related to the implementation of the Food, Drug, Cosmetic Act related to compounding, HR 3204. Issues related to the introduction of the Saving Access to Compounded Medications for Special Needs Patients Act, S. 1406. Issues related to reimbursement of compounded medications and recommended changes to the Social Security Act; drug pricing (no specific bills). Pharmacy inspection issues and concerns (no specific bills).
TEST Act of 2015
Client: THE INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS · Firm: ROSE LAW FIRM, A PROFESSIONAL ASSOCIATION
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
THE INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS via ROSE LAW FIRM, A PROFESSIONAL ASSOCIATION
2017 · third_quarter · 3T
Issues related to health care as they impact compounding pharmacists (no specific bills).
Issues related to Medicare/Medicaid reimbursement of compounded medications and recommended changes to the Social Security Act; drug pricing (no specific bills).
Source: Senate LDA
Legislation related to the implementation of the Food, Drug, Cosmetic Act related to compounding, HR 3204. Issues related to the introduction of the Saving Access to Compounded Medications for Special Needs Patients Act, S. 1406. Issues related to reimbursement of compounded medications and recommended changes to the Social Security Act; drug pricing (no specific bills). Pharmacy inspection issues and concerns (no specific bills).
TEST Act of 2015
Client: THE INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS · Firm: ROSE LAW FIRM, A PROFESSIONAL ASSOCIATION
Legislation related to the implementation of the Food, Drug, Cosmetic Act related to compounding, HR 3204. Issues related to the introduction of the Saving Access to Compounded Medications for Special Needs Patients Act, S. 1406. Issues related to reimbursement of compounded medications and recommended changes to the Social Security Act; drug pricing (no specific bills). Pharmacy inspection issues and concerns (no specific bills).
TEST Act of 2015
Client: THE INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS · Firm: ROSE LAW FIRM, A PROFESSIONAL ASSOCIATION
Legislation related to the implementation of the Food, Drug, Cosmetic Act related to compounding, HR 3204. Issues related to the introduction of the Saving Access to Compounded Medications for Special Needs Patients Act, S. 1406. Issues related to reimbursement of compounded medications and recommended changes to the Social Security Act; drug pricing (no specific bills).
Saving Access to Compounded Medications for Special Needs Patients Act
Client: THE INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS · Firm: ROSE LAW FIRM, A PROFESSIONAL ASSOCIATION
Issues related to health care as they impact compounding pharmacists (no specific bills). S.1406 - Saving Access to Compounded Medications for Special Needs Patients Act.
Saving Access to Compounded Medications for Special Needs Patients Act
Client: THE INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS · Firm: ROSE LAW FIRM, A PROFESSIONAL ASSOCIATION
Legislation related to the implementation of the Food, Drug, Cosmetic Act related to compounding, HR 3204. Issues related to the introduction of the Saving Access to Compounded Medications for Special Needs Patients Act, S. 1406. Issues related to reimbursement of compounded medications and recommended changes to the Social Security Act; drug pricing (no specific bills). Pharmacy inspection issues and concerns (no specific bills).
Saving Access to Compounded Medications for Special Needs Patients Act
Client: THE INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS · Firm: ROSE LAW FIRM, A PROFESSIONAL ASSOCIATION
Legislation related to the implementation of the Food, Drug, Cosmetic Act related to compounding, HR 3204. Issues related to the introduction of the Saving Access to Compounded Medications for Special Needs Patients Act, S. 1406. Issues related to reimbursement of compounded medications and recommended changes to the Social Security Act; drug pricing (no specific bills).
Saving Access to Compounded Medications for Special Needs Patients Act
Client: THE INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS · Firm: ROSE LAW FIRM, A PROFESSIONAL ASSOCIATION
Legislation related to the implementation of the Food, Drug, Cosmetic Act related to compounding, HR 3204. Issues related to the introduction of the Saving Access to Compounded Medications for Special Needs Patients Act, S. 1406. Issues related to reimbursement of compounded medications and recommended changes to the Social Security Act; drug pricing (no specific bills). Pharmacy inspection issues and concerns (no specific bills).
Saving Access to Compounded Medications for Special Needs Patients Act
Client: THE INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS · Firm: ROSE LAW FIRM, A PROFESSIONAL ASSOCIATION
Issues related to health care as they impact compounding pharmacists (no specific bills). S.1406 - Saving Access to Compounded Medications for Special Needs Patients Act.
Saving Access to Compounded Medications for Special Needs Patients Act
Client: THE INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS · Firm: ROSE LAW FIRM, A PROFESSIONAL ASSOCIATION
Issues related to health care as they impact compounding pharmacists (no specific bills). S.1406 - Saving Access to Compounded Medications for Special Needs Patients Act.
Saving Access to Compounded Medications for Special Needs Patients Act
Client: THE INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS · Firm: ROSE LAW FIRM, A PROFESSIONAL ASSOCIATION
Issues related to health care as they impact compounding pharmacists (no specific bills). S.1406 - Saving Access to Compounded Medications for Special Needs Patients Act.
Saving Access to Compounded Medications for Special Needs Patients Act
Client: THE INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS · Firm: ROSE LAW FIRM, A PROFESSIONAL ASSOCIATION
Legislation related to the implementation of the Food, Drug, Cosmetic Act related to compounding, HR 3204. Issues related to the introduction of the Saving Access to Compounded Medications for Special Needs Patients Act, S. 1406. Issues related to reimbursement of compounded medications and recommended changes to the Social Security Act; drug pricing (no specific bills). Pharmacy inspection issues and concerns (no specific bills).
TEST Act of 2015
Client: THE INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS · Firm: ROSE LAW FIRM, A PROFESSIONAL ASSOCIATION
Legislation related to the implementation of the Food, Drug, Cosmetic Act related to compounding, HR 3204. Issues related to the introduction of the Saving Access to Compounded Medications for Special Needs Patients Act, S. 1406.
Saving Access to Compounded Medications for Special Needs Patients Act
Client: THE INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS · Firm: ROSE LAW FIRM, A PROFESSIONAL ASSOCIATION
Issues related to health care as they impact compounding pharmacists (no specific bills). S.1406 - Saving Access to Compounded Medications for Special Needs Patients Act.
Saving Access to Compounded Medications for Special Needs Patients Act
Client: THE INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS · Firm: ROSE LAW FIRM, A PROFESSIONAL ASSOCIATION
Legislation related to the implementation of the Food, Drug, Cosmetic Act related to compounding, HR 3204. Issues related to the introduction of the Saving Access to Compounded Medications for Special Needs Patients Act, S. 1406.
Issues related to appropriations that would impact compounding pharmacies and pharmacists (no specific bills). Issues related to waste, fraud and abuse of funds and benefits (no specific bills). All FDA/AG appropriations and Omnibus legislation impacting compounding pharmacists. Issues related to the National Defense Authorization Act and TRICARE, drug reimbursements, cost-sharing requirements for pharmacy benefits.
Legislative efforts related to the implementation of the Food, Drug and Cosmetic Act, and the Drug Quality and Security Act (P.L 113-54). Issues related to reimbursement of compounded medications and recommended changes to the Social Security Act; drug pricing (no specific bills). Pharmacy inspection issues and concerns (no specific bills).
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
THE INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS via ROSE LAW FIRM, A PROFESSIONAL ASSOCIATION
2017 · second_quarter · Q2
Issues related to Medicare/Medicaid reimbursement of compounded medications and recommended changes to the Social Security Act; drug pricing (no specific bills).
Issues related to appropriations that would impact compounding pharmacies and pharmacists (no specific bills). Issues related to waste, fraud and abuse of funds and benefits (no specific bills). All FDA/AG appropriations and Omnibus legislation impacting compounding pharmacists. Issues related to the National Defense Authorization Act and TRICARE, drug reimbursements, cost-sharing requirements for pharmacy benefits.
Legislative efforts related to the implementation of the Food, Drug and Cosmetic Act, and the Drug Quality and Security Act (P.L 113-54). Issues related to reimbursement of compounded medications and recommended changes to the Social Security Act; drug pricing (no specific bills). Pharmacy inspection issues and concerns (no specific bills).
Issues related to health care as they impact compounding pharmacists (no specific bills).
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
YGRENE ENERGY FUND via ROSE LAW FIRM, A PROFESSIONAL ASSOCIATION
2017 · second_quarter · RR
Issues and legislation pertaining to residential and commercial financing for clean energy options.
THE INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS via ROSE LAW FIRM, A PROFESSIONAL ASSOCIATION
2017 · first_quarter · Q1
Issues related to appropriations that would impact compounding pharmacies and pharmacists (no specific bills). Issues related to waste, fraud and abuse of funds and benefits (no specific bills). All FDA/AG appropriations and Omnibus legislation impacting compounding pharmacists. Issues related to the National Defense Authorization Act and TRICARE, drug reimbursements, cost-sharing requirements for pharmacy benefits.
Legislative efforts related to the implementation of the Food, Drug and Cosmetic Act, and the Drug Quality and Security Act (P.L 113-54). Issues related to reimbursement of compounded medications and recommended changes to the Social Security Act; drug pricing (no specific bills). Pharmacy inspection issues and concerns (no specific bills).
Issues related to health care as they impact compounding pharmacists (no specific bills).
Issues related to Medicare/Medicaid reimbursement of compounded medications and recommended changes to the Social Security Act; drug pricing (no specific bills).
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
THE INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS via ROSE LAW FIRM, A PROFESSIONAL ASSOCIATION
2016 · fourth_quarter · Q4
Legislation related to the implementation of the Food, Drug, Cosmetic Act related to compounding, HR 3204. Issues related to the introduction of the Saving Access to Compounded Medications for Special Needs Patients Act, S. 1406. Issues related to reimbursement of compounded medications and recommended changes to the Social Security Act; drug pricing (no specific bills). Pharmacy inspection issues and concerns (no specific bills).
Issues related to Medicare/Medicaid reimbursement of compounded medications and recommended changes to the Social Security Act; drug pricing (no specific bills).
Issues related to appropriations that would impact compounding pharmacies and pharmacists (no specific bills). Issues related to waste, fraud and abuse of funds and benefits (no specific bills). All FDA/AG appropriations and Omnibus legislation impacting compounding pharmacists. Issues related to the National Defense Authorization Act and TRICARE, drug reimbursements, cost-sharing requirements for pharmacy benefits.
Issues related to health care as they impact compounding pharmacists (no specific bills). S.1406 - Saving Access to Compounded Medications for Special Needs Patients Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
THE INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS via ROSE LAW FIRM, A PROFESSIONAL ASSOCIATION
2016 · third_quarter · Q3
Issues related to appropriations that would impact compounding pharmacies and pharmacists (no specific bills). Issues related to waste, fraud and abuse of funds and benefits (no specific bills). All FDA/AG appropriations and Omnibus legislation impacting compounding pharmacists. Issues related to the National Defense Authorization Act and TRICARE, drug reimbursements, cost-sharing requirements for pharmacy benefits.
Issues related to Medicare/Medicaid reimbursement of compounded medications and recommended changes to the Social Security Act; drug pricing (no specific bills).
THE INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS via ROSE LAW FIRM, A PROFESSIONAL ASSOCIATION
2016 · second_quarter · Q2
Issues related to Medicare/Medicaid reimbursement of compounded medications and recommended changes to the Social Security Act; drug pricing (no specific bills).
Issues related to health care as they impact compounding pharmacists (no specific bills). S.1406 - Saving Access to Compounded Medications for Special Needs Patients Act.
Issues related to appropriations that would impact compounding pharmacies and pharmacists (no specific bills). Issues related to waste, fraud and abuse of funds and benefits (no specific bills). All FDA/AG appropriations and Omnibus legislation impacting compounding pharmacists. Issues related to the National Defense Authorization Act and TRICARE, drug reimbursements, cost-sharing requirements for pharmacy benefits.
THE INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS via ROSE LAW FIRM, A PROFESSIONAL ASSOCIATION
2016 · first_quarter · Q1
Issues related to appropriations that would impact compounding pharmacies and pharmacists (no specific bills). Issues related to waste, fraud and abuse of funds and benefits (no specific bills). All FDA/AG appropriations and Omnibus legislation impacting compounding pharmacists. Issues related to the National Defense Authorization Act and TRICARE, drug reimbursements, cost-sharing requirements for pharmacy benefits.
Issues related to health care as they impact compounding pharmacists (no specific bills). S.1406 - Saving Access to Compounded Medications for Special Needs Patients Act.
THE INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS via ROSE LAW FIRM, A PROFESSIONAL ASSOCIATION
2015 · fourth_quarter · RA
Issues that impact compounding pharmacists as related to: the Affordable Care Act; the Controlled Substances Act and DEA regulatory activity; implementation of the Food, Drug and Cosmetic Act; Medicare/Medicaid reimbursement of compounded medications and recommended changes to the Social Security Act; waste, fraud and abuse of Medicare/Medicaid benefits; TRICARE and PBMs; pharmaceuticals for animals requested by veterinarians.
Issues that impact compounding pharmacists as related to: the Affordable Care Act; the Controlled Substances Act and DEA regulatory activity; implementation of the Food, Drug and Cosmetic Act; Medicare/Medicaid reimbursement of compounded medications and recommended changes to the Social Security Act; waste, fraud and abuse of Medicare/Medicaid benefits; TRICARE and PBMs; pharmaceuticals for animals requested by veterinarians.
THE INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS via ROSE LAW FIRM, A PROFESSIONAL ASSOCIATION
2015 · fourth_quarter · 4A
Issues related to appropriations that would impact compounding pharmacies and pharmacists (no specific bills). Issues related to waste, fraud and abuse of funds and benefits (no specific bills). All FDA/AG appropriations and Omnibus legislation impacting compounding pharmacists.
Issues related to Medicare/Medicaid reimbursement of compounded medications and recommended changes to the Social Security Act; drug pricing (no specific bills).
Issues related to health care as they impact compounding pharmacists (no specific bills). S.1406 - Saving Access to Compounded Medications for Special Needs Patients Act.
THE INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS via ROSE LAW FIRM, A PROFESSIONAL ASSOCIATION
2015 · fourth_quarter · RR
Issues that impact compounding pharmacists as related to: the Affordable Care Act; the Controlled Substances Act and DEA regulatory activity; implementation of the Food, Drug and Cosmetic Act; Medicare/Medicaid reimbursement of compounded medications and recommended changes to the Social Security Act; waste, fraud and abuse of Medicare/Medicaid benefits; TRICARE and PBMs; pharmaceuticals for animals requested by veterinarians.
Issues that impact compounding pharmacists as related to: the Affordable Care Act; the Controlled Substances Act and DEA regulatory activity; implementation of the Food, Drug and Cosmetic Act; Medicare/Medicaid reimbursement of compounded medications and recommended changes to the Social Security Act; waste, fraud and abuse of Medicare/Medicaid benefits; TRICARE and PBMs; pharmaceuticals for animals requested by veterinarians.
Legislation related to the implementation of the Food, Drug, Cosmetic Act related to compounding, HR 3204. Issues related to the introduction of the Saving Access to Compounded Medications for Special Needs Patients Act, S. 1406. Issues related to reimbursement of compounded medications and recommended changes to the Social Security Act; drug pricing (no specific bills). Pharmacy inspection issues and concerns (no specific bills).
Issues related to health care as they impact compounding pharmacists (no specific bills). S.1406 - Saving Access to Compounded Medications for Special Needs Patients Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Legislation related to the implementation of the Food, Drug, Cosmetic Act related to compounding, HR 3204. Issues related to the introduction of the Saving Access to Compounded Medications for Special Needs Patients Act, S. 1406. Issues related to reimbursement of compounded medications and recommended changes to the Social Security Act; drug pricing (no specific bills). Pharmacy inspection issues and concerns (no specific bills).
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Issues related to Medicare/Medicaid reimbursement of compounded medications and recommended changes to the Social Security Act; drug pricing (no specific bills).
Legislation related to the implementation of the Food, Drug, Cosmetic Act related to compounding, HR 3204. Issues related to the introduction of the Saving Access to Compounded Medications for Special Needs Patients Act, S. 1406. Issues related to reimbursement of compounded medications and recommended changes to the Social Security Act; drug pricing (no specific bills).
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Issues that impact compounding pharmacists as related to: the Affordable Care Act; the Controlled Substances Act and DEA regulatory activity; implementation of the Food, Drug and Cosmetic Act; Medicare/Medicaid reimbursement of compounded medications and recommended changes to the Social Security Act; waste, fraud and abuse of Medicare/Medicaid benefits; TRICARE and PBMs; pharmaceuticals for animals requested by veterinarians.
Issues that impact compounding pharmacists as related to: the Affordable Care Act; the Controlled Substances Act and DEA regulatory activity; implementation of the Food, Drug and Cosmetic Act; Medicare/Medicaid reimbursement of compounded medications and recommended changes to the Social Security Act; waste, fraud and abuse of Medicare/Medicaid benefits; TRICARE and PBMs; pharmaceuticals for animals requested by veterinarians.
Issues that impact compounding pharmacists as related to: the Affordable Care Act; the Controlled Substances Act and DEA regulatory activity; implementation of the Food, Drug and Cosmetic Act; Medicare/Medicaid reimbursement of compounded medications and recommended changes to the Social Security Act; waste, fraud and abuse of Medicare/Medicaid benefits; TRICARE and PBMs; pharmaceuticals for animals requested by veterinarians.
Issues that impact compounding pharmacists as related to: the Affordable Care Act; the Controlled Substances Act and DEA regulatory activity; implementation of the Food, Drug and Cosmetic Act; Medicare/Medicaid reimbursement of compounded medications and recommended changes to the Social Security Act; waste, fraud and abuse of Medicare/Medicaid benefits; TRICARE and PBMs; pharmaceuticals for animals requested by veterinarians.
Issues that impact compounding pharmacists as related to: the Affordable Care Act; the Controlled Substances Act and DEA regulatory activity; implementation of the Food, Drug and Cosmetic Act; Medicare/Medicaid reimbursement of compounded medications and recommended changes to the Social Security Act; waste, fraud and abuse of Medicare/Medicaid benefits; TRICARE and PBMs; pharmaceuticals for animals requested by veterinarians.
Legislation related to the implementation of the Food, Drug, Cosmetic Act related to compounding, HR 3204. Issues related to the introduction of the Saving Access to Compounded Medications for Special Needs Patients Act, S. 1406.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Issues that impact compounding pharmacists as related to: the Affordable Care Act; the Controlled Substances Act and DEA regulatory activity; implementation of the Food, Drug and Cosmetic Act; Medicare/Medicaid reimbursement of compounded medications and recommended changes to the Social Security Act; waste, fraud and abuse of Medicare/Medicaid benefits; TRICARE and PBMs; pharmaceuticals for animals requested by veterinarians.
Issues that impact compounding pharmacists as related to: the Affordable Care Act; the Controlled Substances Act and DEA regulatory activity; implementation of the Food, Drug and Cosmetic Act; Medicare/Medicaid reimbursement of compounded medications and recommended changes to the Social Security Act; waste, fraud and abuse of Medicare/Medicaid benefits; TRICARE and PBMs; pharmaceuticals for animals requested by veterinarians.
Issues that impact compounding pharmacists as related to: the Affordable Care Act; the Controlled Substances Act and DEA regulatory activity; implementation of the Food, Drug and Cosmetic Act; Medicare/Medicaid reimbursement of compounded medications and recommended changes to the Social Security Act; waste, fraud and abuse of Medicare/Medicaid benefits; TRICARE and PBMs; pharmaceuticals for animals requested by veterinarians.
Issues that impact compounding pharmacists as related to: the Affordable Care Act; the Controlled Substances Act and DEA regulatory activity; implementation of the Food, Drug and Cosmetic Act; Medicare/Medicaid reimbursement of compounded medications and recommended changes to the Social Security Act; waste, fraud and abuse of Medicare/Medicaid benefits; TRICARE and PBMs; pharmaceuticals for animals requested by veterinarians.
Issues that impact compounding pharmacists as related to: the Affordable Care Act; the Controlled Substances Act and DEA regulatory activity; implementation of the Food, Drug and Cosmetic Act; Medicare/Medicaid reimbursement of compounded medications and recommended changes to the Social Security Act; waste, fraud and abuse of Medicare/Medicaid benefits; TRICARE and PBMs; pharmaceuticals for animals requested by veterinarians.